Clinical trials
Pulmonary clinical trials
Below are recruiting pulmonary clinical trials, each written for real people, not researchers. We’re tracking 1,310 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06401512Recruiting
Digital follow-up for COPD patients in primary care
This trial tests a digital follow-up program for people with COPD who live at home. It aims to help manage your condition with remote support from your healthcare team.
Bergen, NorwayAges 35–80 - NCT06404164Recruiting
3D Lung Map to Guide Small Nodule Surgery
This trial tests a new way to guide lung surgery by using a 3D map of the lung's natural zones (watersheds) to find the best spot to remove a small lung nodule. It aims to help doctors remove just the right amount of lung tissue while preserving as much healthy lung as possible.
Guangzhou, GuangdongAges Any age - NCT06412172Recruiting
Natural history study of lung papillomatosis
This study is for people with HPV-related recurrent respiratory papillomatosis (RRP) that has spread to the lungs. Doctors will follow your health over time and study the condition to learn more about how it progresses.
New Haven, ConnecticutAges 18–99 - NCT06425627Recruiting
Spinal vs general anesthesia for hip fracture surgery in older adults
This study compares two types of anesthesia—spinal (awake, lower body numb) versus general (completely asleep)—for people 65 and older having hip fracture surgery. The goal is to see which is better for preventing lung complications after surgery.
Wuhan, HubeiAges 65 years+ - NCT06426628Recruiting
Nasal swab test for lung nodule risk
This trial tests a new nasal swab test to help doctors better understand your risk if you have a small lung nodule. The test looks at cells from your nose to give more information about whether the nodule might be cancer, without needing a biopsy right away.
Hartford, ConnecticutAges 29–85 - NCT06429579Recruiting
Potts shunt for severe pulmonary hypertension in children
This trial tests a surgery called a Potts shunt for children with severe pulmonary hypertension (high blood pressure in the lungs). It may help children who are still very sick despite standard medications.
Beijing, Beijing MunicipalityAges 6 months–18 years - NCT06431776RecruitingPhase 3
Inhaled molgramostim for kids with autoimmune PAP
This study tests an inhaled medicine called molgramostim for children with autoimmune pulmonary alveolar proteinosis (aPAP), a rare lung condition. The goal is to see if the drug can improve lung function and reduce the need for whole lung lavage (a washing procedure).
MünchenAges 6–18 - NCT06436625Recruiting
Outpatient rehab for lung cancer patients on immunotherapy
This study tests whether a structured outpatient exercise program can help people with non-small cell lung cancer who are already receiving immunotherapy. It is designed for those whose cancer is stable or responding after initial treatment.
ViennaAges 18–120 - NCT06443580Recruiting
A mind-body program for pulmonary hypertension
This trial tests a program that helps you notice and manage body signals (like breathlessness) to improve how you feel day-to-day. It is designed for people with any type of pulmonary hypertension.
Glasgow, ClydebankAges 18 years+ - NCT06445686Recruiting
Monitoring Vital Signs in Idiopathic Pulmonary Fibrosis
This study monitors your vital signs before and after a sudden worsening (flare-up) of IPF. It uses a wearable device (Bora Band®) to track your health and help doctors better understand and manage these events.
RennesAges 18 years+ - NCT06454838Recruiting
Exercise and blood vessel health in children with pulmonary hypertension
This study looks at how exercise affects the lungs, blood vessels, and oxygen use in children with pulmonary arterial hypertension (high blood pressure in the lungs). It compares them to healthy children to understand how the condition impacts the body.
Ankara, ÇankayaAges 6–18 - NCT06476210RecruitingPhase 4
New drug combo for drug-resistant tuberculosis
This trial tests a three-drug combination (bedaquiline, delamanid, and linezolid) to see if it's safe and works well for people with multi-drug resistant or rifampicin-resistant tuberculosis. It may offer a new treatment option if standard drugs aren't working.
Hefei, AnhuiAges 18 years+ - NCT06480435Recruiting
Chest physiotherapy and lung squeezing for men with COPD
This study explores whether a chest physiotherapy technique (called lung squeezing) can help men with moderate-to-severe COPD breathe more easily. Participants will receive the therapy and be monitored for improvements.
Lahore, Punjab ProvinceAges 40–60 - NCT06480422Recruiting
Breathing exercises for moderate COPD
This study tests two breathing exercises—autogenic drainage and segmental breathing—to see if they help people with moderate COPD breathe easier. It may help you clear mucus and improve your lung function.
Lahore, Punjab ProvinceAges 40–60 - NCT05999721Recruiting
Nerve block for better breathing after heart surgery
This trial is testing a nerve block (a numbing injection) placed near the breastbone to see if it helps your lungs work better after heart surgery. If you are having planned heart surgery through a breastbone cut, you may be able to join.
Petah TikvaAges 18 years+ - NCT06488495Recruiting
Exercise program for nontuberculous mycobacterium lung disease
This trial tests whether a structured exercise program can improve symptoms and quality of life in people with nontuberculous mycobacterial (NTM) lung disease. If you have a confirmed NTM lung infection and are having respiratory symptoms, this study may help you build strength and better manage your condition.
SeoulAges 40–80 - NCT06491043RecruitingPhase 2
Stem cells for COPD: safety and early effectiveness study
This trial tests whether an infusion of donor stem cells can help people with moderate to severe COPD breathe easier. If you are a current or former smoker aged 40 to 80, your symptoms are stable, and your lung function meets specific targets, you may be able to join.
New Taipei CityAges 40–80 - NCT06499363Recruiting
Treprostinil for pulmonary hypertension in newborns
This study collects information on how well a medicine called treprostinil works and how safe it is for newborn babies with pulmonary hypertension (high blood pressure in the lungs). It is for babies who have already received this treatment as part of their regular care.
BronAges Up to 10 months - NCT06532071RecruitingPhase 2
Advanced MRI imaging for pulmonary fibrosis
This study tests whether advanced MRI scans can better detect and track lung scarring in people with certain types of pulmonary fibrosis. It may help doctors understand how well your treatment is working, without extra radiation from CT scans.
Boston, MassachusettsAges 18–80 - NCT06533371Recruiting
Ultrasound for emphysema in COPD and lung cancer
This study uses ultrasound (a safe, painless sound wave test) to check for emphysema (damaged air sacs in the lungs) in people with COPD or those being screened for lung cancer. It aims to see if ultrasound can replace the need for CT scans.
Acquaviva delle FontiAges 18 years+ - NCT06538376Recruiting
New portable chest X-ray for ICU patients
This study tests a new portable chest X-ray that can be used in the ICU to check for problems like fluid in the lungs, trouble breathing, or swallowing issues. It is designed to help doctors see these problems more easily without moving you to the radiology department.
Boston, MassachusettsAges 18 years+ - NCT06541353Recruiting
Predicting heart function after a pulmonary embolism
This study uses heart signals and blood tests to predict how well your heart will recover over a year after a pulmonary embolism. It may help doctors tailor your care based on your personal risk.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06544148Recruiting
Measuring lung artery pressure with a chest belt in ICU patients
This study tests a new way to measure blood pressure in your lung artery using a special belt that sends small electrical signals through your chest. It may help doctors monitor your heart and lungs without extra invasive procedures.
BernAges 18 years+ - NCT06557876Recruiting
Pulse field ablation for atrial fibrillation mechanics
This study tests if a new type of energy called pulse field ablation (a procedure that uses short bursts of electric pulses) works as well as standard ablation for restoring normal heart rhythm in patients with episodes of irregular heartbeat. It may help your heart pump more normally.
Paris, FranceAges 18 years+
Hear when a new Pulmonary trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pulmonary?
- Yes. Clin2 currently lists 1,310 recruiting pulmonary studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pulmonary trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pulmonary trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.